GE Healthcare and NIBRT Join Forces to Boost Talent Growth in Single-Use Bioprocessing

Marlborough, MA, United States and Dublin, Ireland – September 11, 2019 – GE Healthcare (GEHC) and the National Institute of Bioprocessing Research and Training (NIBRT) in Dublin, Ireland are combining their expertise to deliver educational programming on biopharmaceutical and cell therapy development and manufacturing. As part of the collaboration, GE Healthcare and NIBRT will share... Read more

GE Healthcare Partnership Takes Aim at Brain Aneurysms with AI

SYDNEY- August 9, 2019 –GE Healthcare, Fujitsu Australia, Macquarie University and Macquarie Medical Imaging today announced announced a new research collaboration to diagnose and monitor brain aneurysms on scans faster and more efficiently using artificial intelligence (AI) . The project has already received a Cooperative Research Centres Projects (CRC-P) grant of AU$2.1M from the Department... Read more

GE HEALTHCARE AND NYANSA FORM STRATEGIC ALLIANCE TO BRING NETWORK PERFORMANCE ANALYTICS SOLUTIONS TO HEALTH CARE

Chicago and Palo Alto, CA – June 10, 2019— GE Healthcare and Nyansa today announced a strategic alliance under which GE Healthcare will distribute and support the Nyansa Voyance AIOps platform for health care customers. The arrangement, for the first time, provides an advanced analytics solution for biomed and IT professionals to address the increasingly... Read more

GE Healthcare and Rockwell Automation Collaborate to Drive the Next Generation of Bioprocessing Automation

March 28, 2019 Collaboration will help drug manufacturers improve efficiencies, get to market faster and deliver personalized medicines with innovative solutions Joint work is pivotal step in transforming biopharmaceutical manufacturing to meet the needs of the biopharma 4.0 era Chicago, IL and Milwaukee, WI, US – March 28, 2019 – GE Healthcare and Rockwell Automation are combining their... Read more

GE Healthcare and World Courier collaborate to drive commercialization of cell and gene therapies

Chicago, IL, US, May 28, 2019 – GE Healthcare and World Courier, a part of AmerisourceBergen, are combining their expertise in manufacturing and logistics to better patient access to cell and gene therapies. Together, they aim to create a seamless end-to-end supply chain that will enable the developers of these treatments to meet increasing global... Read more

GE Healthcare announces commercial launch of Chronicle™ automation software for cell therapy

May 15, 2019 – GE Healthcare builds on its digital capabilities with the Chronicle web application, the next generation development of my.Cryochain™ software now supporting the complete cell therapy workflow. Chronicle automation software is a GMP compliant fit-for-purpose digital solution designed to optimize complex cell therapy process development and manufacturing. With real-time supply chain tracking,... Read more

GE Healthcare and Indi Molecular to collaborate on diagnostic tool for clinical management of immunotherapy patients

Chalfont St Giles, UK & Culver City, CA, May 14 2019 – GE Healthcare and Indi Molecular, Inc, a  California-based biotechnology company, have announced plans to develop immune cell-targeted Positron-Emission Tomography (PET) tracer candidates, based on Indi Molecular’s proprietary Protein Catalyzed Capture (PCC) technology. These tracer candidates, if successful, could help identify molecular markers of cytotoxic T-cells,... Read more